Josefien Buddeke1, Michiel L Bots2, Ineke van Dis3, Anho Liem4, Frank L J Visseren5, Ilonca Vaartjes6. 1. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Dutch Heart Foundation, The Hague, The Netherlands. Electronic address: j.buddeke-2@umcutrecht.nl. 2. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Dutch Heart Foundation, The Hague, The Netherlands. 4. Department of Cardiology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands. 5. Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. 6. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands; Dutch Heart Foundation, The Hague, The Netherlands.
Abstract
BACKGROUND: We determined trends over time in cardiovascular and non-cardiovascular comorbidity in patients hospitalised for cardiovascular disease (CVD). METHODS: The Dutch nationwide hospital register was used to identify patients hospitalised for CVD during 2000-2010. Comorbidity was defined as a previous hospital admission for CVD other than the index CVD, cancer, diabetes, musculoskeletal and connective tissue disorders, respiratory disorders, thyroid gland disorders, kidney disorders and dementia in the five years previous to hospital admittance for the index CVD. Trends were calculated in strata of age and sex and for different types of CVD: coronary heart disease (CHD), cerebrovascular disease (CVA), heart failure (HF) and peripheral arterial disease (PAD). RESULTS: We identified 2,397,773 admissions for CVD between 2000 and 2010. Comorbidity was present in 38%. In HF, PAD, CHD and CVA this was 54%, 46%, 40%, and 32%, respectively. Between 2000 and 2010, the percentage of patients with comorbidity increased (+1.1%), this increase was most pronounced in patients ≥75years (+3.0%). Cardiovascular disease was the most frequent comorbid condition, though became less prevalent over time (men -5%; women: -2%), whereas non-cardiovascular comorbidity increased in men (+4%), and remained similar in women (-1%). Cancer was the most common non-cardiovascular comorbid condition and increased in men and women (men: +5%; women: +4%). CONCLUSIONS: Comorbid conditions are highly prevalent in patients hospitalised for CVD, especially HF and PAD patients. In older patients, prevalences increased over time. Cardiovascular diseases were the most common comorbid condition, though the prevalence decreased over the study period whereas the prevalence of cancer increased.
BACKGROUND: We determined trends over time in cardiovascular and non-cardiovascular comorbidity in patients hospitalised for cardiovascular disease (CVD). METHODS: The Dutch nationwide hospital register was used to identify patients hospitalised for CVD during 2000-2010. Comorbidity was defined as a previous hospital admission for CVD other than the index CVD, cancer, diabetes, musculoskeletal and connective tissue disorders, respiratory disorders, thyroid gland disorders, kidney disorders and dementia in the five years previous to hospital admittance for the index CVD. Trends were calculated in strata of age and sex and for different types of CVD: coronary heart disease (CHD), cerebrovascular disease (CVA), heart failure (HF) and peripheral arterial disease (PAD). RESULTS: We identified 2,397,773 admissions for CVD between 2000 and 2010. Comorbidity was present in 38%. In HF, PAD, CHD and CVA this was 54%, 46%, 40%, and 32%, respectively. Between 2000 and 2010, the percentage of patients with comorbidity increased (+1.1%), this increase was most pronounced in patients ≥75years (+3.0%). Cardiovascular disease was the most frequent comorbid condition, though became less prevalent over time (men -5%; women: -2%), whereas non-cardiovascular comorbidity increased in men (+4%), and remained similar in women (-1%). Cancer was the most common non-cardiovascular comorbid condition and increased in men and women (men: +5%; women: +4%). CONCLUSIONS: Comorbid conditions are highly prevalent in patients hospitalised for CVD, especially HF and PAD patients. In older patients, prevalences increased over time. Cardiovascular diseases were the most common comorbid condition, though the prevalence decreased over the study period whereas the prevalence of cancer increased.
Authors: Josefien Buddeke; Michiel L Bots; Ineke van Dis; Frank Lj Visseren; Monika Hollander; François G Schellevis; Ilonca Vaartjes Journal: Br J Gen Pract Date: 2019-05-07 Impact factor: 5.386
Authors: Elles M Screever; Martje H L van der Wal; Dirk J van Veldhuisen; Tiny Jaarsma; Astrid Koops; Kuna S van Dijk; Janke Warink-Riemersma; Jenifer E Coster; B Daan Westenbrink; Peter van der Meer; Rudolf A de Boer; Wouter C Meijers Journal: Clin Res Cardiol Date: 2022-08-17 Impact factor: 6.138
Authors: Tian-Tian Ma; Ian C K Wong; Kenneth K C Man; Yang Chen; Thomas Crake; Muhiddin A Ozkor; Ling-Qing Ding; Zi-Xuan Wang; Lin Zhang; Li Wei Journal: PLoS One Date: 2019-01-18 Impact factor: 3.240
Authors: P Jepma; G Ter Riet; M van Rijn; C H M Latour; R J G Peters; W J M Scholte Op Reimer; B M Buurman Journal: Neth Heart J Date: 2019-03 Impact factor: 2.380
Authors: Gideon B Valstar; Sophie H Bots; Floor Groepenhoff; Aisha Gohar; Frans H Rutten; Tim Leiner; Maarten Jan Maria Cramer; Arco J Teske; Leonardo P Suciadi; Roxana Menken; Gerard Pasterkamp; Folkert W Asselbergs; Leonard Hofstra; Michael L Bots; Hester M den Ruijter Journal: BMJ Open Date: 2019-06-05 Impact factor: 2.692
Authors: Chiara Andrade Silva; Agnaldo José Lopes; Jannis Papathanasiou; Luis Felipe Fonseca Reis; Arthur Sá Ferreira Journal: Medicina (Kaunas) Date: 2022-06-18 Impact factor: 2.948